Provention Bio to Present at Two Upcoming Virtual Investor Conferences
News provided by
Share this article
Share this article
RED BANK, N.J., March 4, 2021 /PRNewswire/ Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in two upcoming virtual investor conferences in March.
H.C. Wainwright Global Life Sciences Conference
Andrew Drechsler, Provention Bio s Chief Financial Officer will provide a corporate update at the H.C. Wainwright Global Life Sciences Conference. The webcast will be available beginning Tuesday, March 9, 2021, at 7:00 am E.T and can be accessed by visiting the Events and Webcasts section of the Company s website: http://investors.proventionbio.com/events.
PRIME MINISTER RECEIVES HIS FIRST DOSE OF COVID-19 VACCINE
Prime Minister of Dominica, Honourable Roosevelt Skerrit took his first dose of the Oxford AstraZeneca Vaccine on Tuesday, February 24 2021.
This as the Government of Dominica through the Ministry of Health, Wellness and New Health Investments continues the roll-out of the Covid-19 vaccine as Dominica attempts to build immunity against the Covid-19 disease.
Prime Minister Skerrit encouraged citizens to put aside the fears caused by baseless conspiracy theories that are currently circulating. He stated that citizens should use the opportunity for vaccine as it is for their own protection and the protection of their families.
OraSure Technologies, Inc Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.